Cargando...
Cancer nanomedicine: Is targeting our target?
Nanomedicine may have a delivery problem. Rigorous, realistic and holistic rethinking is needed to improve nanomedicine performance and increase patient benefit.
Gardado en:
| Publicado en: | Nat Rev Mater |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5034892/ https://ncbi.nlm.nih.gov/pubmed/27668091 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/natrevmats.2016.69 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|